Volume 16, Number 1—January 2010
Research
Norovirus Gastroenteritis Outbreak with a Secretor-independent Susceptibility Pattern, Sweden
Table 1
Antigen and secretor status | No. (%) symptomatic persons, n = 33 | No. (%) asymptomatic/ nonexposed persons, n = 50† | Total no. (%) persons, n = 83 | Normal distribution, % (95% CI)†‡ |
---|---|---|---|---|
Blood type (n = 68) | ||||
A | 14 (44) | 18 (56) | 32 (47) | 47 (37–56) |
B | 2 (17) | 10 (83) | 12 (18) | 15 (8–22) |
O | 10 (43) | 13 (57) | 23 (34) | 33 (23–40) |
AB |
0 |
1 (100) |
1 (1) |
7 (2–12) |
Lewis (n = 83) | ||||
Lea+b– | 7 (58) | 5 (42) | 12 (14) | 18 (11–26) |
Lea–b+ | 23 (38) | 38 (62) | 61 (73) | 76 (68–84) |
Lea–b– |
3 (30) |
7 (70) |
10 (12) |
6 (1–10) |
Secretor status (n = 83) | ||||
Secretor§ | 26 (38) | 42 (62) | 68 (82) | 80 (72–88) |
Nonsecretor | 7 (47) | 8 (53) | 15 (18) | 20 (12–28) |
*ABO blood group could only be determined for the 68 secretor-positive persons (26 symptomatic and 42 asymptomatic). CI, confidence interval.
†p>0.15
‡See Larsson et al. (27).
§Homozygous and heterozygous.
Page created: March 31, 2011
Page updated: March 31, 2011
Page reviewed: March 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.